PL2262486T3 - Kompozycja kwetiapiny - Google Patents

Kompozycja kwetiapiny

Info

Publication number
PL2262486T3
PL2262486T3 PL09777586T PL09777586T PL2262486T3 PL 2262486 T3 PL2262486 T3 PL 2262486T3 PL 09777586 T PL09777586 T PL 09777586T PL 09777586 T PL09777586 T PL 09777586T PL 2262486 T3 PL2262486 T3 PL 2262486T3
Authority
PL
Poland
Prior art keywords
quetiapine
composition
quetiapine composition
Prior art date
Application number
PL09777586T
Other languages
English (en)
Inventor
Matej Pavli
Rok Dreu
Sasa Baumgartner
Odon Planinsek
Robert Pisek
Franc Vrecer
Miha Vrbinc
Original Assignee
Krka Tovarna Zdravil D D Novo Mesto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41112567&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2262486(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from SI200800193A external-priority patent/SI22850A/sl
Application filed by Krka Tovarna Zdravil D D Novo Mesto filed Critical Krka Tovarna Zdravil D D Novo Mesto
Publication of PL2262486T3 publication Critical patent/PL2262486T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
PL09777586T 2008-08-01 2009-07-31 Kompozycja kwetiapiny PL2262486T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SI200800193A SI22850A (sl) 2008-08-01 2008-08-01 Pripravek kvetiapina
SI200900073 2009-03-18
PCT/EP2009/005573 WO2010012490A1 (en) 2008-08-01 2009-07-31 Quetiapine composition
EP09777586A EP2262486B1 (en) 2008-08-01 2009-07-31 Quetiapine composition

Publications (1)

Publication Number Publication Date
PL2262486T3 true PL2262486T3 (pl) 2013-06-28

Family

ID=41112567

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09777586T PL2262486T3 (pl) 2008-08-01 2009-07-31 Kompozycja kwetiapiny

Country Status (10)

Country Link
EP (1) EP2262486B1 (pl)
DE (1) DE202009018024U1 (pl)
DK (1) DK2262486T3 (pl)
EA (1) EA018638B1 (pl)
ES (1) ES2402342T3 (pl)
HR (1) HRP20130245T1 (pl)
PL (1) PL2262486T3 (pl)
PT (1) PT2262486E (pl)
SI (1) SI2262486T1 (pl)
WO (1) WO2010012490A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009265099A1 (en) * 2008-07-01 2010-01-07 Lupin Limited Sustained release pharmaceutical compositions comprising Quetiapine
EP2373319B1 (en) * 2009-01-05 2013-07-31 Torrent Pharmaceuticals Limited Sustained release pharmaceutical composition of quetiapine and process for preparation thereof
EP2233130A1 (en) * 2009-03-23 2010-09-29 Genepharm (Europe) Trading Limited A sustained release oral composition of an antipsychotic agent
WO2011154118A1 (en) 2010-06-07 2011-12-15 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Quetiapine prolonged-release tablets
TR201008261A1 (tr) 2010-10-08 2012-04-24 Sanovel İlaç San. Ve Ti̇c. A.Ş. Kontrollü salım gerçekleştiren ketiapin formülasyonları
DE102011115690A1 (de) 2011-10-11 2013-04-11 Acino Pharma Ag Quetiapin enthaltende Formulierungen
EP2846812A2 (en) * 2012-05-10 2015-03-18 FMC Corporation Controlled release solid dose form
JP6866560B2 (ja) 2015-06-18 2021-04-28 エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ エステトロール成分を含有する口腔内崩壊性投与単位
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607684D0 (en) * 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
GB8705574D0 (en) 1987-03-10 1987-04-15 Ici Plc Preparation of thiazepine compound
GB9611328D0 (en) 1996-05-31 1996-08-07 Zeneca Ltd Pharmaceutical compositions
GB9716161D0 (en) 1997-08-01 1997-10-08 Zeneca Ltd Process
IT1297461B1 (it) 1997-10-29 1999-12-17 Ciocca Maurizio Preparazione di compresse a rilascio controllato a base di complessi tra carragenano e farmaci basici solubili
GB9922271D0 (en) 1999-09-21 1999-11-17 Zeneca Ltd Formulation
HU227039B1 (en) 2000-01-25 2010-05-28 Egis Gyogyszergyar Nyilvanosan New process for the production of quetiapine and intermediates therefor
US6287599B1 (en) 2000-12-20 2001-09-11 Shire Laboratories, Inc. Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles
AR034517A1 (es) 2001-06-21 2004-02-25 Astrazeneca Ab Formulacion farmaceutica
JP3624954B1 (ja) * 2001-11-07 2005-03-02 藤沢薬品工業株式会社 分散不良薬物の溶出性を改善する方法
IL164155A0 (en) 2002-03-20 2005-12-18 Teva Pharma Crystalline forms of quetiapine hemifumarate
WO2005028457A1 (en) 2003-09-23 2005-03-31 Fermion Oy Preparation of quetiapine
EP1689367A1 (en) 2003-10-21 2006-08-16 Actavis Group HF Pharmaceutical formulations containing quetiapine
AU2006269225B2 (en) 2005-07-07 2011-10-06 Farnam Companies, Inc. Sustained release pharmaceutical compositions for highly water soluble drugs
EP1928849A1 (en) 2005-09-30 2008-06-11 Fermion Oy New crystallization process of quetiapine hemifumarate
EP2131817A2 (en) 2007-03-09 2009-12-16 Synthon B.V. Pharmaceutical composition of quetiapine fumarate
EP2355804A1 (en) 2008-11-26 2011-08-17 Krka Quetiapine composition

Also Published As

Publication number Publication date
PT2262486E (pt) 2013-03-27
ES2402342T3 (es) 2013-04-30
EA018638B1 (ru) 2013-09-30
WO2010012490A1 (en) 2010-02-04
HRP20130245T1 (hr) 2013-04-30
DK2262486T3 (da) 2013-03-25
DE202009018024U1 (de) 2010-12-09
EA201100286A1 (ru) 2011-08-30
SI2262486T1 (sl) 2013-04-30
EP2262486A1 (en) 2010-12-22
EP2262486B1 (en) 2013-01-02

Similar Documents

Publication Publication Date Title
ZA201005268B (en) Composition
GB0815022D0 (en) Composition
GB0819633D0 (en) Composition
GB0822246D0 (en) Composition
GB0818473D0 (en) Composition
GB0810554D0 (en) Herbicde composition
GB0801119D0 (en) Composition
SI2262486T1 (sl) Sestavek kvetiapina
GB0818472D0 (en) Composition
GB0809808D0 (en) Composition
GB0811743D0 (en) Composition
GB0801401D0 (en) Composition
GB0810359D0 (en) Composition
GB0817656D0 (en) Composition
GB0812740D0 (en) Composition
GB0806948D0 (en) Composition
GB0818269D0 (en) Composition
GB0818231D0 (en) Composition
GB0813589D0 (en) Composition
GB0809983D0 (en) Composition
GB0903681D0 (en) Composition
GB0823344D0 (en) Composition
GB0821754D0 (en) Composition
GB0820259D0 (en) Composition
GB0818336D0 (en) Composition